New hope for heart attack survivors with no blocked arteries?
NCT ID NCT05198791
First seen Mar 04, 2026 · Last updated May 16, 2026 · Updated 8 times
Summary
This study tests a drug called eplerenone in people who had a heart attack or heart injury but no blocked arteries. It focuses on those with tiny blood vessel problems. About 400 participants will be split into groups: some get usual care, others get eplerenone. The goal is to see if eplerenone reduces heart damage and improves heart function over six months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOCARDIAL INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Golden Jubilee National Hospital
RECRUITINGGlasgow, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
University Hospital Hairmyres
RECRUITINGEast Kilbride, Lanarkshire, G75 8RG, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.